
(audio-EN) DNA-based therapeutics: enGene successfuly raises CAD $13.5 million
Montreal (Quebec) – enGene, a Montreal-based biotechnology company, has just raised CAD $13.5 million in a Series B investment round led by Forbion Capital Partners, with participation of Lumira Capital and new investors Quebec’s Fonds de solidarité FTQ and Pharmstandard International. Inventor of a disruptive technology based on the idea of turning the gut into […]